Department of Health and Human Services August 16, 2011 – Federal Register Recent Federal Regulation Documents

Center for Scientific Review; Notice of Closed Meetings
Document Number: 2011-20849
Type: Notice
Date: 2011-08-16
Agency: Department of Health and Human Services, National Institutes of Health
Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting
Document Number: 2011-20848
Type: Notice
Date: 2011-08-16
Agency: Department of Health and Human Services, National Institutes of Health
National Heart, Lung, and Blood Institute Notice of Closed Meeting
Document Number: 2011-20845
Type: Notice
Date: 2011-08-16
Agency: Department of Health and Human Services, National Institutes of Health
National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meeting
Document Number: 2011-20830
Type: Notice
Date: 2011-08-16
Agency: Department of Health and Human Services, National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Document Number: 2011-20829
Type: Notice
Date: 2011-08-16
Agency: Department of Health and Human Services, National Institutes of Health
HIT Standards Committee's Workgroup Meetings; Notice of Meetings
Document Number: 2011-20815
Type: Notice
Date: 2011-08-16
Agency: Department of Health and Human Services
Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Study: Disease Information in Branded Promotional Material
Document Number: 2011-20814
Type: Notice
Date: 2011-08-16
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (the PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information and to allow 60 days for public comment in response to the notice. This notice solicits comments on research entitled ``Experimental Study: Disease Information in Branded Promotional Material.'' The proposed research will explore the nature of including information about a disease and promotional information about a specific drug treatment in the same advertising piece.
Agency Information Collection Activities; Proposed Collection; Comment Request; Extra Label Drug Use in Animals
Document Number: 2011-20813
Type: Notice
Date: 2011-08-16
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (the PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the reporting requirements associated with extra label drug use in animals.
HIT Policy Committee's Workgroup Meetings; Notice of Meetings
Document Number: 2011-20811
Type: Notice
Date: 2011-08-16
Agency: Department of Health and Human Services
HIT Standards Committee Advisory Meeting; Notice of Meeting
Document Number: 2011-20809
Type: Notice
Date: 2011-08-16
Agency: Department of Health and Human Services
HIT Policy Committee Advisory Meeting; Notice of Meeting
Document Number: 2011-20808
Type: Notice
Date: 2011-08-16
Agency: Department of Health and Human Services
Hung Ta Fan: Debarment Order
Document Number: 2011-20780
Type: Notice
Date: 2011-08-16
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is issuing an order under the Federal Food, Drug, and Cosmetic Act (the FD&C Act) debarring Hung Ta Fan for a period of 5 years from importing articles of food or offering such articles for importation into the United States. FDA bases this order on a finding that Mr. Fan was convicted of a felony under Federal law for conduct relating to the importation into the United States of an article of food. Mr. Fan was given notice of the proposed debarment and an opportunity to request a hearing within the timeframe prescribed by regulation. As of July 13, 2011 (30 days after receipt of the notice), Mr. Fan had not responded. Mr. Fan's failure to respond constitutes a waiver of his right to a hearing concerning this action.
Draft Guidance for Industry and Food and Drug Administration Staff; Procedures for Handling Section 522 Postmarket Surveillance Studies; Availability
Document Number: 2011-20727
Type: Notice
Date: 2011-08-16
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing the availability of the draft guidance entitled ``Procedures for Handling Section 522 Postmarket Surveillance Studies.'' This guidance document is intended to assist device manufacturers subject to a section 522 postmarket surveillance order imposed by FDA by providing an overview of section 522 of the Federal Food, Drug, and Cosmetic Act (the FD&C Act), procedural information on how to fulfill section 522 obligations, and recommendations on the format, content, and review of postmarket surveillance study submissions. This draft guidance is not final nor is it in effect at this time.
Notice To Announce the Award of an Urgent Single-Source Grant to Survivors of Torture International (SOTI) in San Diego, CA
Document Number: 2011-20714
Type: Notice
Date: 2011-08-16
Agency: Department of Health and Human Services, Office of Refugee Resettlement, Refugee Resettlement Office, Children and Families Administration
Notice is hereby given that an urgent single-source grant is awarded to Survivors of Torture, International (SOTI), San Diego, CA. The grant will support direct services to persons who have experienced trauma or torture prior to their arrival in the United States. The grant will serve San Diego County, which is the area that has received the greatest number of Iraqi refugee arrivals, as well as a high percentage of other refugees and asylum-seekers. The grantee, SOTI, will provide comprehensive rehabilitative services to Iraqi and other survivors of torture, who are in need of specialized services that will enable these survivors to regain their health and independence and rebuild productive lives. In addition to provision of direct services, SOTI will train other area service providers to more effectively serve this population. SOTI will also focus on sustaining collaborations among providers serving this population. According to the Department of Homeland Security (DHS), in FY 2009, twenty-eight percent of the country's asylum-seekers came to California for resettlement. In 2010, a total of 3,663 refugees were resettled in San Diego. At least 159,550 refugees, asylees, and asylum-seekers in San Diego have come from areas where torture may be practiced. San Diego's numbers include an influx in Iraqi refugees, as one in four Iraqi refugees has resettled in California, with the vast majority resettling in San Diego. SOTI is the only program in San Diego County that provides medical affidavits for torture survivors to use in claiming asylum. They have also reported an 84 percent increase in client intakes during fiscal years (FYs) 2009 and 2010. As a result, an urgent need exists for specialized services for individuals in San Diego who have suffered torture prior to their arrival in the United States. SOTI is well positioned to provide medical, psychological, social, and legal services to Iraqis who have suffered torture and are relocated in the San Diego area. SOTI has developed a large network of pro bono service providers and possesses the clinical and programmatic expertise to serve survivors of torture. For Further Information Contact: Ronald Munia, Director, Division of Community Resettlement, Office of Refugee Resettlement, 901 D Street, SW., Washington, DC 20047. Telephone: 202-401-4559. E-mail: Ronald.Munia@acf.hhs.gov.
Effective Date of Requirement for Premarket Approval for Three Class III Preamendments Devices
Document Number: 2011-20664
Type: Rule
Date: 2011-08-16
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is issuing a final rule to require the filing of a premarket approval application (PMA) or a notice of completion of a product development protocol (PDP) for the following three class III preamendments devices: Ventricular bypass (assist) device; pacemaker repair or replacement material; and female condom. The Agency has summarized its findings regarding the degree of risk of illness or injury designed to be eliminated or reduced by requiring the devices to meet the statute's approval requirements and the benefits to the public from the use of the devices. This action implements certain statutory requirements.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.